ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 202.9% based on the discounted cash flow analysis.
| Market cap | $2.28 Billion |
|---|---|
| Enterprise Value | $2.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.07 |
| Outstanding Shares | 30,121,685 |
| P/E Ratio | -59.18 |
|---|---|
| PEG | 202.66 |
| Price to Sales | 9.45 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.99 |
| Enterprise Value to EBIT | -108.25 |
| Enterprise Value to Net Income | -57 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5941▼ 0.54% |
|---|---|
| Total Calls | 47,300▼ 98.31% |
| Total Puts | 28,100▼ 98.32% |
Holdings and activity of institutional investors.
| Ownership % | 21.71%▼ 68.65% |
|---|---|
| Total Invested | $551.77M▼ 63.70% |
| Investors Holding | 61▼ 128.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...